Articles
Vol. 69 No. 3 (2025)
Solamargine inhibited the progression of non-small cell lung cancer in vitro by activating T cells
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 September 2025
315
Views
87
Downloads
1
HTML
Authors
Lung cancer is the leading cause of cancer-related death globally and the most common cancer type. Solamargine is an extract from the traditional Chinese medicine, Long Kui, which exhibits antitumor effects in a number of cancer types, including lung cancer. However, the possible association between solamargine and the tumor microenvironment (TME) in non-small cell lung cancer (NSCLC) remains to be elucidated. In the present study, Cell Counting Kit-8 and 5-Ethynyl-2'-deoxyuridine (EdU) assays were used to evaluate the viability and proliferation of NSCLC cells, respectively. In addition, NSCLC cells were co-cultured with peripheral blood mononuclear cells with or without prior solamargine treatment to evaluate the possible association between solamargine and the TME. The results indicated that solamargine can inhibit NSCLC cell proliferation and migration directly. In addition, it was demonstrated that solamargine can prevent the progression of NSCLC indirectly via activating the function of T cells. These findings may provide a novel theoretical basis in drug discovery for the treatment of NSCLC.
Downloads
Download data is not yet available.
Citations
Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Lung Cancer treatment advances in 2022. Cancer Invest 2023;41:12-24. DOI: https://doi.org/10.1080/07357907.2022.2119479
2. Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 2020;41:1-24. DOI: https://doi.org/10.1016/j.ccm.2019.10.001
3. Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am 2019;103:463-73. DOI: https://doi.org/10.1016/j.mcna.2018.12.006
4. Li Y, Wu X, Yang P, Jiang G, Luo Y. Machine learning for lung cancer diagnosis, treatment, and prognosis. Genomics Proteomics Bioinformatics 2022;20:850-66. DOI: https://doi.org/10.1016/j.gpb.2022.11.003
5. Rybak-Wolf A, Stottmeister C, Glažar P, Jens M, Pino N, Giusti S, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 2015;58:870-85. DOI: https://doi.org/10.1016/j.molcel.2015.03.027
6. Arneth B. Tumor microenvironment. Medicina (Kaunas) 2019;56:15. DOI: https://doi.org/10.3390/medicina56010015
7. Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 2021;221:107753. DOI: https://doi.org/10.1016/j.pharmthera.2020.107753
8. Pei H, Yang J, Li W, Luo X, Xu Y, Sun X, et al. Solanum nigrum Linn.: advances in anti-cancer activity and mechanism in digestive system tumors. Med Oncol 2023;40:311. DOI: https://doi.org/10.1007/s12032-023-02167-7
9. Qu X, Xie J, Zhang Y, Wang Z. Solamargine alleviates proliferation and metastasis of cervical cancer cells by blocking the CXCL3-mediated Erk signaling pathway. Evid Based Complement Alternat Med 2022;2022:7634754. DOI: https://doi.org/10.1155/2022/7634754
10. Han Y, Shi J, Xu Z, Zhang Y, Cao X, Yu J, et al. Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids. Front Pharmacol 2022;13:802168. DOI: https://doi.org/10.3389/fphar.2022.802168
11. Huang S, Sun M, Ren Y, Luo T, Wang X, Weng G, Cen D. Solamargine induces apoptosis of human renal carcinoma cells via downregulating phosphorylated STAT3 expression. Oncol Lett 2023;26:493. DOI: https://doi.org/10.3892/ol.2023.14080
12. Tang Q, Zheng F, Wu J, Xiao Q, Li L, Hann SS. Combination of solamargine and metformin strengthens IGFBP1 gene expression through inactivation of Stat3 and reciprocal interaction between FOXO3a and SP1. Cell Physiol Biochem 2017;43:2310-26. DOI: https://doi.org/10.1159/000484383
13. Zhou Y, Tang Q, Zhao S, Zhang F, Li L, Wu W, et al. Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells. Tumour Biol 2014;35:8169-78. DOI: https://doi.org/10.1007/s13277-014-2047-1
14. Zhao Z, Jia Q, Wu MS, Xie X, Wang Y, Song G, et al. Degalactotigonin, a natural compound from Solanum nigrum L., Inhibits growth and metastasis of osteosarcoma through GSK3β inactivation-mediated repression of the Hedgehog/Gli1 pathway. Clin Cancer Res 2018;24:130-44. DOI: https://doi.org/10.1158/1078-0432.CCR-17-0692
15. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29. DOI: https://doi.org/10.3322/caac.21254
16. Di Maio M, De Marinis F, Hirsch FR, Gridelli C. Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review). Int J Oncol 2014;45:509-15. DOI: https://doi.org/10.3892/ijo.2014.2453
17. Martins GZ, Moreira RR, Planeta CS, Almeida AE, Bastos JK, Salgueiro L, et al. Effects of the extract and glycoalkaloids of Solanum lycocarpum St. Hill on Giardia lamblia trophozoites. Pharmacogn Mag 2015;11:S161-5. DOI: https://doi.org/10.4103/0973-1296.157721
18. Sani IK, Marashi SH, Kalalinia F. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. Toxicol In Vitro 2015;29:893-900. DOI: https://doi.org/10.1016/j.tiv.2015.03.012
19. Chen Y, Tang Q, Wu J, Zheng F, Yang L, Hann SS. Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells. J Exp Clin Cancer Res 2015;34:154. DOI: https://doi.org/10.1186/s13046-015-0272-0
20. Tang Q, Zheng F, Liu Z, Wu J, Chai X, He C, et al. Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer. J Cell Mol Med 2019;23:7749-61. DOI: https://doi.org/10.1111/jcmm.14649
21. Fu R, Wang X, Hu Y, Du H, Dong B, Ao S, et al. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. Int J Oncol 2019;54:1545-54. DOI: https://doi.org/10.3892/ijo.2019.4744
22. Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms controlling PD-L1 expression in cancer. Mol Cell 2019;76:359-70. DOI: https://doi.org/10.1016/j.molcel.2019.09.030
23. Wherry EJ. T cell exhaustion. Nat Immunol 2011;12:492-9. DOI: https://doi.org/10.1038/ni.2035
24. Nguyen LT, Ohashi PS. Clinical blockade of PD1 and LAG3--potential mechanisms of action. Nat Rev Immunol 2015;15:45-56. DOI: https://doi.org/10.1038/nri3790
25. Ai L, Xu A, Xu J. Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond. Adv Exp Med Biol 2020;1248:33-59. DOI: https://doi.org/10.1007/978-981-15-3266-5_3
How to Cite
1.
Zhang C, Sun Y, Jiang W, Wu L, Fang Q, Wang Q. Solamargine inhibited the progression of non-small cell lung cancer in vitro by activating T cells. Eur J Histochem [Internet]. 2025 Sep. 1 [cited 2025 Dec. 28];69(3). Available from: https://www.ejh.it/ejh/article/view/4217
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
